相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。High Expression of Bcl-2 Protein Predicts Favorable Outcome in Non-small Cell Lung Cancer: Evidence from a Systematic Review and Meta-analysis
Xian-Da Zhao et al.
ASIAN PACIFIC JOURNAL OF CANCER PREVENTION (2014)
Targeting of MCL-1 kills MYC-driven mouse and human lymphomas even when they bear mutations in p53
Gemma L. Kelly et al.
GENES & DEVELOPMENT (2014)
t(14;18) Translocation: A Predictive Blood Biomarker for Follicular Lymphoma
Sandrine Roulland et al.
JOURNAL OF CLINICAL ONCOLOGY (2014)
Risk of Subsequent Malignant Neoplasms in Long-Term Hereditary Retinoblastoma Survivors After Chemotherapy and Radiotherapy
Jeannette R. Wong et al.
JOURNAL OF CLINICAL ONCOLOGY (2014)
Checkpoint blockade cancer immunotherapy targets tumour-specific mutant antigens
Matthew M. Gubin et al.
NATURE (2014)
Cell competition is a tumour suppressor mechanism in the thymus
Vera C. Martins et al.
NATURE (2014)
CANCER Darwinian tumour suppression
Eduardo Moreno
NATURE (2014)
Age-related mutations associated with clonal hematopoietic expansion and malignancies
Mingchao Xie et al.
NATURE MEDICINE (2014)
Death to the losers
Gines Morata et al.
SCIENCE (2014)
An ancient defense system eliminates unfit cells from developing tissues during cell competition
S. N. Meyer et al.
SCIENCE (2014)
Ionizing radiations sustain glioblastoma cell dedifferentiation to a stem-like phenotype through survivin: possible involvement in radioresistance
P. Dahan et al.
CELL DEATH & DISEASE (2014)
Mimicking the microenvironment in chronic lymphocytic leukaemia where does the journey go?
Daniela Asslaber et al.
BRITISH JOURNAL OF HAEMATOLOGY (2013)
Compensatory proliferation and apoptosis-induced proliferation: a need for clarification
B. Mollereau et al.
CELL DEATH AND DIFFERENTIATION (2013)
Senescence and aging: the critical roles of p53
A. Rufini et al.
ONCOGENE (2013)
Inhibition of apoptosis by BCL2 prevents leukemic transformation of a murine myelodysplastic syndrome
Christopher I. Slape et al.
BLOOD (2012)
Mimicking the tumour microenvironment: three different co-culture systems induce a similar phenotype but distinct proliferative signals in primary chronic lymphocytic leukaemia cells
Emma Hamilton et al.
BRITISH JOURNAL OF HAEMATOLOGY (2012)
Mcl-1 Phosphorylation Defines ABT-737 Resistance That Can Be Overcome by Increased NOXA Expression in Leukemic B cells
Suparna Mazumder et al.
CANCER RESEARCH (2012)
Bone Marrow Failure in Fanconi Anemia Is Triggered by an Exacerbated p53/p21 DNA Damage Response that Impairs Hematopoietic Stem and Progenitor Cells
Raphael Ceccaldi et al.
CELL STEM CELL (2012)
Apoptosis and oncogenesis: give and take in the BCL-2 family
Fabien Llambi et al.
CURRENT OPINION IN GENETICS & DEVELOPMENT (2011)
Apoptosis: A Barrier Against Cancer No More?
Florian Baumgartner et al.
HEPATOLOGY (2011)
Spontaneous abrogation of the G(2) DNA damage checkpoint has clinical benefits but promotes leukemogenesis in Fanconi anemia patients
Raphael Ceccaldi et al.
JOURNAL OF CLINICAL INVESTIGATION (2011)
PUMA-mediated intestinal epithelial apoptosis contributes to ulcerative colitis in humans and mice
Wei Qiu et al.
JOURNAL OF CLINICAL INVESTIGATION (2011)
Caspase 3-mediated stimulation of tumor cell repopulation during cancer radiotherapy
Qian Huang et al.
NATURE MEDICINE (2011)
Cancer stem cells in solid tumors: Is 'evading apoptosis' a hallmark of cancer?
Heiko Enderling et al.
PROGRESS IN BIOPHYSICS & MOLECULAR BIOLOGY (2011)
Fanconi Anemia
Jean Soulier
HEMATOLOGY-AMERICAN SOCIETY OF HEMATOLOGY EDUCATION PROGRAM (2011)
Suppression of B-cell lymphomagenesis by the BH3-only proteins Bmf and Bad
Anna Frenzel et al.
BLOOD (2010)
High expression of BCL-2 predicts favorable outcome in non-small cell lung cancer patients with non squamous histology
Valsamo K. Anagnostou et al.
BMC CANCER (2010)
BCL2 in breast cancer: a favourable prognostic marker across molecular subtypes and independent of adjuvant therapy received
S-J Dawson et al.
BRITISH JOURNAL OF CANCER (2010)
PUMA-mediated tumor suppression A tale of two stories
Verena Labi et al.
CELL CYCLE (2010)
p53-Mediated Hematopoietic Stem and Progenitor Cell Competition
Tanya Bondar et al.
CELL STEM CELL (2010)
Apoptosis of leukocytes triggered by acute DNA damage promotes lymphoma formation
Verena Labi et al.
GENES & DEVELOPMENT (2010)
Apoptosis-promoted tumorigenesis: γ-irradiation-induced thymic lymphomagenesis requires Puma-driven leukocyte death
Ewa M. Michalak et al.
GENES & DEVELOPMENT (2010)
Hepatocyte-Specific Deletion of the Antiapoptotic Protein Myeloid Cell Leukemia-1 Triggers Proliferation and Hepatocarcinogenesis in Mice
Achim Weber et al.
HEPATOLOGY (2010)
Irradiation Selects for p53-Deficient Hematopoietic Progenitors
Andriy Marusyk et al.
PLOS BIOLOGY (2010)
Concurrent up-regulation of BCL-XL and BCL2A1 induces approximately 1000-fold resistance to ABT-737 in chronic lymphocytic leukemia
Meike Vogler et al.
BLOOD (2009)
Paradoxical Dependencies of Tumor Dormancy and Progression on Basic Cell Kinetics
Heiko Enderling et al.
CANCER RESEARCH (2009)
Super competition as a possible mechanism to pioneer precancerous fields
Christa Rhiner et al.
CARCINOGENESIS (2009)
Puma and to a lesser extent Noxa are suppressors of Myc-induced lymphomagenesis
E. M. Michalak et al.
CELL DEATH AND DIFFERENTIATION (2009)
Apoptotic Cells Provide an Unexpected Source of Wnt3 Signaling to Drive Hydra Head Regeneration
Simona Chera et al.
DEVELOPMENTAL CELL (2009)
Knockout of Myeloid Cell Leukemia-1 Induces Liver Damage and Increases Apoptosis Susceptibility of Murine Hepatocytes
Binje Vick et al.
HEPATOLOGY (2009)
BCL-2 Expression is Prognostic for Improved Survival in Non-small Cell Lung Cancer
Daniel J. Renouf et al.
JOURNAL OF THORACIC ONCOLOGY (2009)
MYC-induced myeloid leukemogenesis is accelerated by all six members of the antiapoptotic BCL family
L. J. Beverly et al.
ONCOGENE (2009)
Suppression of the DNA damage response in acute myeloid leukemia versus myelodysplastic syndrome
S. Boehrer et al.
ONCOGENE (2009)
Apoptosis and cancer: the genesis of a research field
Thomas G. Cotter
NATURE REVIEWS CANCER (2009)
Unleashing the power of inhibitors of oncogenic kinases through BH3 mimetics
Mark S. Cragg et al.
NATURE REVIEWS CANCER (2009)
ABT-263: A potent and orally bioavailable Bcl-2 family inhibitor
Christin Tse et al.
CANCER RESEARCH (2008)
Targeting the Bcl-2-regulated apoptosis pathway by BH3 mimetics: a breakthrough in anticancer therapy?
V. Labi et al.
CELL DEATH AND DIFFERENTIATION (2008)
Distinct mechanisms of apoptosis-induced compensatory proliferation in proliferating and differentiating tissues in the Drosophila eye
Yun Fan et al.
DEVELOPMENTAL CELL (2008)
Selection against PUMA gene expression in Myc-driven B-cell lymphomagenesis
Sean P. Garrison et al.
MOLECULAR AND CELLULAR BIOLOGY (2008)
Prognostic value of Bcl-2 in breast cancer patients treated with neoadjuvant anthracycline based chemotherapy
Laura M. Vargas-Roig et al.
MOLECULAR ONCOLOGY (2008)
Wound repair and regeneration
Geoffrey C. Gurtner et al.
NATURE (2008)
Cancer-related inflammation
Alberto Mantovani et al.
NATURE (2008)
Cancer Survivorship: A Pediatric Perspective
Wendy Landier et al.
ONCOLOGIST (2008)
Apoptosis-induced compensatory proliferation. The Cell is dead. Long live the Cell!
Yun Fan et al.
TRENDS IN CELL BIOLOGY (2008)
The BCL2 rheostat in glucocorticoid-induced apoptosis of acute lymphoblastic leukemia
C. Ploner et al.
LEUKEMIA (2008)
Engulfment is required for cell competition
Wei Li et al.
CELL (2007)
Hepatocellular carcinoma: Epidemiology and molecular carcinogenesis
Hashem B. El-Serag et al.
GASTROENTEROLOGY (2007)
Can loss of apoptosis protect against cancer?
Dominik Wodarz et al.
TRENDS IN GENETICS (2007)
Myelodysplastic syndromes: the complexity of stem-cell diseases
Seth J. Corey et al.
NATURE REVIEWS CANCER (2007)
Chronic lymphocytic leukemia requires BCL2 to sequester prodeath BIM, explaining sensitivity to BCL2 antagonist ABT-737
Victoria Del Gaizo Moore et al.
JOURNAL OF CLINICAL INVESTIGATION (2007)
Hyperactive Ras in developmental disorders and cancer
Suzanne Schubbert et al.
NATURE REVIEWS CANCER (2007)
Targeting the death machinery in mammary epithelial cells: Implications for breast cancer from transgenic and tissue culture experiments
Richard Jaeger
CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY (2007)
Mdm2 is critically and continuously required to suppress lethal p53 activity in vivo
Ingo Ringshausen et al.
CANCER CELL (2006)
Bim and Bad mediate imatinib-induced killing of Bcr/Abl+ leukemic cells, and resistance due to their loss is overcome by a BH3 mimetic (vol 103, pg 14907, 2006)
Junya Kuroda et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2006)
Bim and Bad mediate imatinib-induced killing of Bcr/Abl+ leukemic cells, and resistance due to their loss is overcome by a BH3 mimetic
Junya Kuroda et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2006)
The pathological response to DNA damage does not contribute to p53-mediated tumour suppression
M. A. Christophorou et al.
NATURE (2006)
BH3-only proteins in cell death initiation, malignant disease and anticancer therapy
V. Labi et al.
CELL DEATH AND DIFFERENTIATION (2006)
BH3-only proteins Puma and Bim are rate-limiting for γ-radiation- and glucocorticoid-induced apoptosis of lymphoid cells in vivo
M Erlacher et al.
BLOOD (2005)
Drug resistance in cancer: Principles of emergence and prevention
NL Komarova et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2005)
Caspase-independent cell death
G Kroemer et al.
NATURE MEDICINE (2005)
Death squads enlisted by the tumour suppressor p53
E Michalak et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2005)
Chronic lymphocytic leukemia cells display p53-dependent drug-induced Puma upregulation
WJM Mackus et al.
LEUKEMIA (2005)
Bim is a suppressor of Myc-induced mouse B cell leukemia
A Egle et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2004)
Multiple cell death pathways as regulators of tumour initiation and progression
M Jäättelä
ONCOGENE (2004)
dMyc transforms cells into super-competitors
E Moreno et al.
CELL (2004)
RAS, FLT3, and TP53 mutations in therapy-related myeloid malignancies with abnormalities of chromosomes 5 and 7
LE Side et al.
GENES CHROMOSOMES & CANCER (2004)
Pathways of apoptotic and non-apoptotic death in tumour cells
H Okada et al.
NATURE REVIEWS CANCER (2004)
Compensatory proliferation induced by cell death Drosophila wing disc requires activity of the apical cell death caspase dronc in a nonapoptotic role requires
JR Huh et al.
CURRENT BIOLOGY (2004)
Expression and transcriptional regulation of functionally distinct Bmf isoforms in B-chronic lymphocytic leukemia cells
AA Morales et al.
LEUKEMIA (2004)
Caspase inhibition during apoptosis causes abnormal signalling and developmental aberrations in Drosophila
A Pérez-Garijo et al.
DEVELOPMENT (2004)
Detection of apoptosis during planarian regeneration by the expression of apoptosis-related genes and TUNEL assay
JS Hwang et al.
GENE (2004)
Apoptotic cells can induce compensatory cell proliferation through the JNK and the wingless signaling pathways
HD Ryoo et al.
DEVELOPMENTAL CELL (2004)
p53- and drug-induced apoptotic responses mediated by BH3-only proteins Puma and Noxa
A Villunger et al.
SCIENCE (2003)
Second cancers after radiotherapy: any evidence for radiation-induced genomic instability?
AJ Sigurdson et al.
ONCOGENE (2003)
Phosphorylation of Bim-EL by Erk1/2 on serine 69 promotes its degradation via the proteasome pathway and regulates its proapoptotic function
F Luciano et al.
ONCOGENE (2003)
Puma is an essential mediator of p53-dependent and -independent apoptotic pathways
JR Jeffers et al.
CANCER CELL (2003)
Lymphoma development in Bax transgenic mice is inhibited by Bcl-2 and associated with chromosomal instability
JJ Luke et al.
CELL DEATH AND DIFFERENTIATION (2003)
Granulocyte colony-stimulating factor inhibits spontaneous cytochrome c release and mitochondria-dependent apoptosis of myelodysplastic syndrome hematopoietic progenitors
R Tehranchi et al.
BLOOD (2003)
The prognostic influence of bcl-2 in malignant glioma
FE McDonald et al.
BRITISH JOURNAL OF CANCER (2002)
Apoptosis and prognostic factors in myelodysplastic syndromes
K Shimazaki et al.
LEUKEMIA & LYMPHOMA (2002)
Apoptosis inhibitor as a suppressor of tumor progression: expression of Bcl-2 eliminates selective advantages for p53-deficient cells in the tumor
KV Gurova et al.
CANCER BIOLOGY & THERAPY (2002)
Bcl-2 is a useful prognostic marker in Dukes' B colon cancer
SH Meterissian et al.
ANNALS OF SURGICAL ONCOLOGY (2001)
bcl-2 expression and apoptosis in primary and metastatic breast carcinomas
E Villar et al.
TUMOR BIOLOGY (2001)
DNA double-strand breaks: signaling, repair and the cancer connection
KK Khanna et al.
NATURE GENETICS (2001)
The DNA damage response: putting checkpoints in perspective
BBS Zhou et al.
NATURE (2000)
Nora, a BH3-only member of the Bcl-2 family and candidate mediator of p53-induced apoptosis
E Oda et al.
SCIENCE (2000)
The ARF/p53 pathway
CJ Sherr et al.
CURRENT OPINION IN GENETICS & DEVELOPMENT (2000)
分享论文
